Utility of TAE in treatment of HCC studied on a long term obsavation of HCC patients with reference to clinical factors

Abstract

A study was made of 102 patients with hepatocellular carcinoma (HCC) 2-10cm in diameter following transcatheter arterial embolization (TAE). It was studied on a long term obsavation. Multivariate analysis proved that the size and the type of tumors were significantly correlated with a prognosis in patients with HCC treated by TAE. Survival rates in the TAE group were evaluated in comparison with those in an untreated group. The groups were previously estimated to be equivalent in the combination of the size and the type of tumors. In nodular typed HCC of 3-5cm and 5-10cm diameter and in massive typed HCC of 5-10cm, the TAE group had a significantly better survival rate than the untreated group. However, the median survival of massive typed HCC of 5-10cm diameter was only 6 months.
This concluded clinically that nodular typed HCC of 3-10cm responded best to TAE.